FDA Approves First and Only Medicine to Treat Cause of Narcolepsy Type 1
Just announced from Takeda Pharmaceuticals: U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only......
Wake Up Narcolepsy (WUN) is a 501(c)(3) nonprofit organization dedicated to driving Narcolepsy awareness, education and research towards improved treatments and a cure.
Narcolepsy by the Numbers
2000
Narcolepsy affects 1 in every 2,000 Americans and 3 million people worldwide.
50
It is estimated that up to 50% of patients with Narcolepsy may be undiagnosed.
20
Typical onset of Narcolepsy is between the ages of 10 and 20 years old, but can occur in early childhood.
6
On average, patients have 6 physician visits before receiving a Narcolepsy diagnosis.
Online Support GroupsFree, online support groups worldwide for people with Narcolepsy and their families. |
National SummitThis one-day summit is for people with Narcolepsy, their families, educators, clinicians and researchers. |
Clinical TrialsPatient engagement in clinical trials help find new ways to treat individuals with Narcolepsy. |
Annual Family WeekendChildren & Teens with Narcolepsy can meet others experiencing the same symptoms and challenges. |
Join Our TeamDo you share our passion for advocating on behalf of those with Narcolepsy? |
What’s New?
-
-
FDA Approves First Drug to Treat the Full Range of Narcolepsy Type 1 Symptoms
FDA News Release: August 05, 2026 – The U.S. Food and Drug Administration today approved......
-
Registration Now Live: 2026 Bridging Perspectives Conference
Join clinical, industry, and community experts for a hybrid educational event where lived experience meets......
-
Wake Up Narcolepsy Announces AASM Foundation 2026 Grant Update
Back in September, Wake Up Narcolepsy (WUN) announced another partnership with the American Academy of......
